台股 » 個股 » 台新藥 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台新藥

(6838)
  • 股價
    34.75
  • 漲跌
    ▲0.70
  • 漲幅
    +2.06%
  • 成交量
    137
  • 產業
    上市 生技醫療類股
  • 20人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
台新藥 (6838)籌碼相關-永豐金-市政 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-市政 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/15033.6500.0034.2502970.01%
2025/01/13034.1000.0033.6003060.01%
2025/01/09234.2000.0034.3023090.65%
2025/01/0600.00136.0535.90-1324-0.31%
2024/12/3000.00137.9537.70-1380-0.26%
2024/12/2400.000.138.2038.00-0.1487-0.02%
2024/12/2300.00138.0538.00-1492-0.20%
2024/12/200.138.0000.0037.650.15050.02%
2024/12/18238.45238.1038.1005270.00%
2024/12/161.538.5100.0038.001.55600.27%
2024/12/100.139.6500.0039.800.16730.01%
2024/12/090.239.70339.8039.60-2.8730-0.38%
2024/12/050.541.1500.0040.450.57830.06%
2024/12/0400.00141.4041.60-1782-0.13%
2024/12/03542.0800.0041.7557860.64%
2024/12/021.143.34143.5043.000.17820.01%
2024/11/2900.00241.0042.50-2767-0.26%
2024/11/28138.5000.0038.6517630.13%
2024/11/26239.4000.0039.3527700.26%
2024/11/21138.90239.2038.90-1784-0.13%
2024/11/18339.8800.0039.9038130.37%
2024/11/15141.7000.0041.7018150.12%
2024/11/13142.5500.0042.6018340.12%
2024/11/1100.00144.2043.60-1967-0.10%
2024/11/0800.00144.3544.40-1973-0.10%
2024/11/0700.005.544.3844.35-5.5977-0.56%
2024/11/05146.60346.9346.55-2978-0.20%
2024/11/0100.00144.5045.30-1966-0.10%
2024/10/3000.00142.7542.50-1964-0.10%
2024/10/22143.7000.0043.7519810.10%
2024/10/17144.6000.0044.5019930.10%
2024/10/151443.862.543.7843.5511.51,0081.14%
2024/10/14344.6300.0044.7531,0010.30%
2024/10/1100.00145.7545.75-1999-0.10%
2024/10/09245.7500.0046.0029910.20%
2024/10/08646.20145.9046.3559850.51%
2024/10/07348.4700.0048.2539700.31%
2024/10/04248.18349.0748.65-1956-0.10%
2024/10/01949.77750.2349.2529350.21%
2024/09/30448.23347.2548.2518800.11%
2024/09/26143.50043.5042.7518350.11%
2024/09/25144.0000.0043.1518350.12%
2024/09/242.343.8900.0043.502.38410.27%
2024/09/23144.30244.4544.45-1830-0.12%
2024/09/201344.75144.5544.60128221.46%
2024/09/1900.00144.2044.90-1817-0.12%
2024/09/18244.20544.4443.95-3802-0.37%
2024/09/16245.031045.6244.65-8798-1.00%
2024/09/131145.692045.8846.05-9778-1.16%
2024/09/12142.65141.9041.9007360.00%
2024/09/11343.60943.8842.50-6723-0.83%
2024/09/1017.545.67645.7945.5011.56941.66%
2024/09/09841.29242.3343.7566350.94%
2024/09/0500.00437.5537.25-4581-0.69%
2024/09/04237.4800.0037.2525790.35%
2024/09/0200.00138.9038.90-1574-0.17%
2024/08/3000.00339.8239.95-3571-0.53%
2024/08/2900.00438.9539.50-4569-0.70%
2024/08/280.138.7500.0038.900.15640.02%
2024/08/27138.85238.8038.65-1558-0.18%
2024/08/26139.0000.0038.9015520.18%
2024/08/22239.58139.7039.5015410.18%
2024/08/2100.00139.2539.20-1534-0.19%
2024/08/20338.434.139.5339.20-1.1529-0.21%
2024/08/19139.200.139.6539.000.95100.18%
2024/08/1600.000.240.0039.65-0.2498-0.04%
2024/08/1500.0011.439.9139.90-11.4489-2.33%
2024/08/1416.339.942.240.0139.5514.14772.95%
2024/08/137.341.115341.1241.95-45.7438-10.41%
〈焦點股〉台新藥眼科新藥出貨至美國展望正向 觸及漲停Anue鉅亨-2024/09/13
〈焦點股〉台新藥眼科新藥9月正式外銷至美國 漲逾半根停板Anue鉅亨-2024/09/06
台新藥 相關文章
台新藥 相關影音